A limit to the divergent allele advantage model supported by variable pathogen recognition across HLA-DRB1 allele lineages

Tissue Antigens

Volumn 86, Issue 5, 2015, Pages 343-352

  Lau, Q ^a   Yasukochi, Y ^b   Satta, Y ^a  

^a GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Allele divergence; Human leukocyte antigen; Major histocompatibility complex; Pathogen recognition

Indexed keywords

HLA DRB1 ANTIGEN;

ADAPTATION; ANTIGEN RECOGNITION; ARTICLE; BALANCING SELECTION; BINDING AFFINITY; BORDETELLA PERTUSSIS; COMPUTER SIMULATION; DIVERGENT ALLELE ADVANTAGE MODEL; GENE FREQUENCY; GENE LOCUS; GENETIC MODEL; HEALTHCARE ASSOCIATED INFECTION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NON PEPTIDE BINDING REGION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHYLOGENY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SIMULATION; ALLELE; ANTIGEN PRESENTATION; BIOLOGICAL MODEL; FEMALE; GENETICS; IMMUNOLOGY; MALE;

ALLELES; ANTIGEN PRESENTATION; COMPUTER SIMULATION; FEMALE; GENETIC LOCI; HLA-DRB1 CHAINS; HUMANS; MALE; MODELS, GENETIC; MODELS, IMMUNOLOGICAL;

EID: 84944061296     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12667     Document Type: Article

References (49)

1. Weitzman JB. Sequence of the major histocompatibility complex. Genome Biol 2000: 1: reports021. DOI: 10.1186/gb-2000-1-1-reports021
2. Bernatchez L, Landry C. MHC studies in nonmodel vertebrates: what have we learned about natural selection in 15 years? J Evol Biol 2003: 16: 363-77.
3. Hughes AL, Yeager M. Natural selection at major histocompatibility complex loci of vertebrates. Annu Rev Genet 1998: 32: 415-35.
4. Spurgin LG, Richardson DS. How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proc R Soc Biol Sci Ser B 2010: 277: 979-88.
5. Hughes AL, Nei M. Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection. Proc Natl Acad Sci USA 1989: 86: 958-62.
6. Doherty PC, Zinkernagel RM. Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature 1975: 256: 50-2.
7. Takahata N, Nei M. Allelic genealogy under overdominant and frequency-dependent selection and polymorphism of major histocompatibility complex loci. Genetics 1990: 124: 967-78.
8. Slade RW, McCallum HI. Overdominant vs. frequency-dependent selection at MHC loci. Genetics 1992: 132: 861-4.
9. Hill AVS. HLA associations with malaria in Africa: some implications for MHC evolution. In: Klein J, Klein D, eds. Molecular Evolution of the Major Histocompatibility Complex. Berlin Heidelberg: Springer, 1991, 403-20.
10. Takahata N. A simple genealogical structure of strongly balanced allelic lines and trans-species evolution of polymorphism. Proc Natl Acad Sci USA 1990: 87: 2419-23.
11. Wakeland EK, Boehme S, She JX et al. Ancestral polymorphisms of MHC class II genes: divergent allele advantage. Immunol Res 1990: 9: 115-22.
12. Lenz TL. Computational prediction of MHC II-antigen binding supports divergent allele advantage and explains trans-species polymorphism. Evolution 2011: 65: 2380-90.
13. Richman AD, Herrera LG, Nash D. MHC class II beta sequence diversity in the deer mouse (Peromyscus maniculatus): implications for models of balancing selection. Mol Ecol 2001: 10: 2765-73.
14. Lenz TL, Mueller B, Trillmich F, Wolf JB. Divergent allele advantage at MHC-DRB through direct and maternal genotypic effects and its consequences for allele pool composition and mating. Proc R Soc Biol Sci Ser B 2013: 280: 20130714.
15. Buhler S, Sanchez-Mazas A. HLA DNA sequence variation among human populations: molecular signatures of demographic and selective events. PLoS One 2011: 6: e14643.
16. Bronson PG, Mack SJ, Erlich HA, Slatkin M. A sequence-based approach demonstrates that balancing selection in classical human leukocyte antigen (HLA) loci is asymmetric. Hum Mol Genet 2013: 22: 252-61.
17. Yasukochi Y, Satta Y. Nonsynonymous substitution rate heterogeneity in the peptide-binding region among different HLA-DRB1 lineages in humans. G3 Genes Genom Genet 2014: 4: 1217-26.
18. Yasukochi Y, Satta Y. A human-specific allelic group of the MHC DRB1 gene in primates. J Physiol Anthropol 2014: 33: 14.
19. Bennett K, Levine T, Ellis JS et al. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol 1992: 22: 1519-24.
20. Chicz RM, Urban RG, Lane WS et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992: 358: 764-8.
21. Brown J, Jardetzky T, Gorga J et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993: 364: 33-9.
22. Nowak MA, Tarczy-Hornoch K, Austyn JM. The optimal number of major histocompatibility complex molecules in an individual. Proc Natl Acad Sci USA Biol Sci 1992: 89: 10896-9.
23. Woelfing B, Traulsen A, Milinski M, Boehm T. Does intra-individual major histocompatibility complex diversity keep a golden mean? Proc R Soc Biol Sci Ser B 2009: 364: 117-28.
24. Wegner KM, Reusch TBH, Kalbe M. Multiple parasites are driving major histocompatibility complex polymorphism in the wild. J Evol Biol 2003: 16: 224-32.
25. Madsen T, Ujvari B. MHC class I variation associates with parasite resistance and longevity in tropical pythons. J Evol Biol 2006: 19: 1973-8.
26. Forsberg LA, Dannewitz J, Petersson E, Grahn M. Influence of genetic dissimilarity in the reproductive success and mate choice of brown trout - females fishing for optimal MHC dissimilarity. J Evol Biol 2007: 20: 1859-69.
27. Hidron AI, Edwards JR, Patel J et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008: 29: 996-1011.
28. Kettaneh A, Seng L, Tiev KP, Tolédano C, Fabre B, Cabane J. Human leukocyte antigens and susceptibility to tuberculosis: a meta-analysis of case-control studies. Int J Tuberc Lung Dis 2006: 10: 717-25.
29. Lyke KE, Fernandez-Vina MA, Cao K et al. Association of HLA alleles with Plasmodium falciparum severity in Malian children. Tissue Antigens 2011: 77: 562-71.
30. Fagerberg J, Askelof P, Wigzell H, Mellstedt H. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides. Cell Immunol 1999: 196: 110-21.
31. Wee A, Teh M, Kang JY. Association of Helicobacter pylori with HLA-DR antigen expression in gastritis. J Clin Pathol 1992: 45: 30-3.
32. Vargas LE, Parra CA, Salazar LM, Guzman F, Pinto M, Patarroyo ME. MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6. Biochem Biophys Res Commun 2003: 307: 148-56.
33. Impens F, Colaert N, Helsens K et al. A quantitative proteomics design for systematic identification of protease cleavage events. Mol Cell Proteomics 2010: 9: 2327-33.
34. Karosiene E, Rasmussen M, Blicher T, Lund O, Buus S, Nielsen M. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. Immunogenetics 2013: 65: 711-24.
35. Huang Lin H, Lan Zhang G, Tongchusak S, Reinherz E, Brusic V. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformat 2008: 9: 1-10.
36. Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001: 17: 1236-7.
37. Sturniolo T, Bono E, Ding J et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999: 17: 555-61.
38. Mack SJ, Cano P, Hollenbach JA et al. Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens 2013: 81: 194-203.
39. Sette A, Vitiello A, Reherman B et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994: 153: 5586-92.
40. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011: 39: D913-9.
41. Crow JF. Some possibilities for measuring selection intensities in man. Hum Biol 1958: 30: 1-13.
42. Evans JD. Straightforward Statistics for the Behavioral Sciences. Pacific Grove: Brooks/Cole Publishing, 1996.
43. Takahata N. MHC diversity and selection. Immunol Rev 1995: 143: 225-47.
44. White TD, Asfaw B, DeGusta D et al. Pleistocene Homo sapiens from Middle Awash, Ethiopia. Nature 2003: 423: 742-7.
45. Mboowa G. Genetics of Sub-Saharan African human population: implications for HIV/AIDS, tuberculosis, and malaria. Int J Evol Biol 2014: 2014: 8.
46. Parikh S, Rosenthal PJ. Human genetics and malaria: relevance for the design of clinical trials. J Infect Dis 2008: 198: 1255-7.
47. Prugnolle F, Manica A, Charpentier M, Guégan JF, Guernier V, Balloux F. Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 2005: 15: 1022-7.
48. Abi-Rached L, Jobin MJ, Kulkarni S et al. The shaping of modern human immune systems by multiregional admixture with archaic humans. Science (New York, NY) 2011: 334: 89-94.
49. De Boer R, Borghans JM, van Boven M, Keşmir C, Weissing F. Heterozygote advantage fails to explain the high degree of polymorphism of the MHC. Immunogenetics 2004: 55: 725-31.